TABPHYN MR is a medication commonly prescribed for the treatment of benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate gland in men. The active ingredient in TABPHYN MR is tamsulosin hydrochloride, which belongs to a class of drugs known as alpha-blockers. Tamsulosin works by relaxing the muscles in the prostate and bladder neck, making it easier to urinate and alleviating the symptoms of BPH such as difficulty in starting the flow of urine, weak stream, and the need to urinate frequently or urgently. TABPHYN MR is formulated as a modified-release capsule, designed to provide a steady release of medication over time, thereby offering consistent symptom relief with once-daily dosing. Patients are advised to follow their healthcare provider's instructions regarding the use and dosage of this medication to achieve the best possible outcome.